Quest Diagnostics Incorporated (DGX) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 201 PAGES: 45

More Info
									          Quest Diagnostics Incorporated (DGX) - Financial and Strategic SWOT
                                   Analysis Review
        Reference Code: GDPH40157FSA                                                                                             Publication Date: APR 2013

          3 Giralda Farms                                  Phone              +1 800 2220446                        Revenue          7,382.6 (million USD)
          Madison, NJ                                      Fax                                                      Net Profit       555.72 (million USD)
          07940                                            Website            www.questdiagnostics.com              Employees        42,000 (Estimated)
                                                                              DGX [New         York    Stock                         Pharmaceuticals           &
          United States                                    Exchange                                                 Industry
                                                                              Exchange]                                              Healthcare

       Company Overview
       Quest Diagnostics Incorporated (Quest) is a medical diagnostics company. It offers diagnostic testing services to the patients and
       physicians in the US through chain of laboratories and company-owned patient service centers. The company offers
       comprehensive services, such as clinical testing, with gene-based and other esoteric test, anatomic pathology services, life
       insurer services, clinical trials testing, healthcare information technology and diagnostic products. The company has two
       reportable business segments, namely, clinical testing business and all other operating segments.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Quest Diagnostics Incorporated, SWOT Analysis
         Stephen H. Rusckowski               Chief Executive Officer                  Strengths                             Weaknesses
         Dan C. Stanzione, Ph.D.             Chairman
                                                                                      Broad Services Portfolio              Declining Revenues
         Dr. Gail R. Wilensky, Ph.D.         Director
                                                                                      Extensive Geographical                Substantial Presence of Debt
         William F. Buehler                  Director
                                                                                      Presence
         John C. Baldwin, M.D.               Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                         Threats

       Share Data                                                                     Changing Demographics                 Reductions in Reimbursement
         Quest Diagnostics Incorporated                                                                                     for Diagnostic Imaging
                                                                                      Emerging Markets
        Share Price (USD) as on 28-Mar-                                56.46                                                Stringent Government
        2013                                                                                                                Regulations
        EPS (USD)                                                        3.92
        Market Cap (million USD)                                       8,933         Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Enterprise Value (million USD)                                12,024
        Shares Outstanding (million)                                     158
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Mar 26, 2013         Cellmid Provides Licenses Update Of Two
                                                                                                           Cancer Diagnostic Tests
                                                                                      Mar 18, 2013         Athena Diagnostics Announces New Genetic
                                                                                                           Testing Services For Rare Neurological
                                                                                                           Disorders
                                                                                      Mar 14, 2013         Quest Diagnostics Announces CFO Transition
                                                                                                           Plan
                                                                                      Mar 05, 2013         Quest    Diagnostics To   Showcase                  Its
                                                                                                           Healthcare IT Connectivity Solutions                At
       Source: Annual Report, Company Website, Primary and Secondary
                                                                                                           HIMSS13
       Research, GlobalData                                                          Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




Quest Diagnostics Incorporated (DGX) - Financial and Strategic                                                                   Reference Code: GDPH40157FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                         Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Quest Diagnostics Incorporated - Key Facts ...................................................................................................................................... 5
       Quest Diagnostics Incorporated - Key Employees ............................................................................................................................. 6
       Quest Diagnostics Incorporated - Key Employee Biographies ........................................................................................................... 8
       Quest Diagnostics Incorporated - Major Products and Services ........................................................................................................ 9
       Quest Diagnostics Incorporated - History ......................................................................................................................................... 10
       Quest Diagnostics Incorporated - Company Statement ................................................................................................................... 14
       Quest Diagnostics Incorporated - Locations And Subsidiaries ......................................................................................................... 17
          Head Office ................................................................................................................................................................................... 17
          Other Locations & Subsidiaries ..................................................................................................................................................... 17
       Section 2 – Company Analysis ......................................................................................................................................................... 20
       Quest Diagnostics Incorporated - Business Description................................................................................................................... 20
       Quest Diagnostics Incorporated - SWOT Analysis ........................................................................................................................... 21
          SWOT Analysis - Overview........................................................................................................................................................... 21
          Quest Diagnostics Incorporated - Strengths ................................................................................................................................. 21
             Strength - Broad Services Portfolio ........................................................................................................................................... 21
             Strength - Extensive Geographical Presence............................................................................................................................ 21
             Strength - Strategic Initiatives ................................................................................................................................................... 21
          Quest Diagnostics Incorporated - Weaknesses ............................................................................................................................ 22
             Weakness - Declining Revenues .............................................................................................................................................. 22
             Weakness - Substantial Presence of Debt ................................................................................................................................ 22
          Quest Diagnostics Incorporated - Opportunities ........................................................................................................................... 22
             Opportunity - Changing Demographics ..................................................................................................................................... 22
             Opportunity - Emerging Markets ............................................................................................................................................... 22
             Opportunity - Inorganic Growth Strategies ................................................................................................................................ 23
          Quest Diagnostics Incorporated - Threats .................................................................................................................................... 23
             Threat - Reductions in Reimbursement for Diagnostic Imaging ................................................................................................ 23
             Threat - Stringent Government Regulations .............................................................................................................................. 23
             Threat - Competition and Technological Changes .................................................................................................................... 23
       Quest Diagnostics Incorporated - Key Competitors.......................................................................................................................... 25
       Section 3 – Company Financial Ratios ............................................................................................................................................. 26
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 26
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 26
       Performance Chart ........................................................................................................................................................................... 28
       Financial Performance...................................................................................................................................................................... 28
       Financial Ratios - Interim Ratios....................................................................................................................................................... 29
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 30
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 31
          Quest Diagnostics Incorporated, Medical Equipment, Deals By Year, 2007 to YTD 2013 ........................................................... 31
          Quest Diagnostics Incorporated, Medical Equipment, Deals By Type, 2007 to YTD 2013 ........................................................... 32
          Quest Diagnostics Incorporated, Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013 .......................................... 33
          Quest Diagnostics Incorporated, Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013 ......................................... 34


Quest Diagnostics Incorporated (DGX) - Financial and Strategic                                                                                                 Reference Code: GDPH40157FSA
SWOT Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Quest Diagnostics Incorporated, Recent Deals Summary................................................................................................................ 35
       Section 5 – Company’s Recent Developments ................................................................................................................................ 36
          Quest Diagnostics Incorporated, Recent Developments............................................................................................................... 36
             Mar 26, 2013: Cellmid Provides Licenses Update Of Two Cancer Diagnostic Tests ................................................................ 36
             Mar 18, 2013: Athena Diagnostics Announces New Genetic Testing Services For Rare Neurological Disorders .................... 36
             Mar 14, 2013: Quest Diagnostics Announces CFO Transition Plan .......................................................................................... 37
             Mar 05, 2013: Quest Diagnostics To Showcase Its Healthcare IT Connectivity Solutions At HIMSS13 ................................... 37
             Feb 21, 2013: LKCF And Quest Diagnostics Announce Partnership To Donate Diagnostic Testing To Patients In Need........ 39
             Jan 23, 2013: Quest Diagnostics Reports Revenue Of $7.4 Billion In 2012.............................................................................. 40
             Dec 04, 2012: Quest Diagnostics Clinical Trials's Biorepository Receives CAP Accreditation.................................................. 41
             Oct 19, 2012: Quest Diagnostics Announces First EHRs Certified Under Laboratory-Based Health IT Quality Solutions
             Program .................................................................................................................................................................................... 41
             Oct 17, 2012: Quest Diagnostics Reports Revenue Of $1.9 Billion In Q3 2012 ........................................................................ 42
             Oct 11, 2012: Quest Diagnostics To Cut 400-600 Management Jobs; Creates Two New Business Structures ....................... 43
       Section 6 – Appendix ....................................................................................................................................................................... 44
          Methodology ................................................................................................................................................................................. 44
          Ratio Definitions ............................................................................................................................................................................ 44
          About GlobalData ............
								
To top